High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis

BACKGROUND: Helicobacter pylori resistance to amoxicillin remains rare in many regions. Proton pump inhibitor-amoxicillin-containing high dose dual therapy (HDDT) has been proposed to treat H. pylori infection. We aimed to assess the effectiveness and safety of PPI-amoxicillin HDDT for treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yang-Jie, Zhang, Yi, Wang, Ting-Yi, Zhao, Jing-Tao, Zhao, Zhe, Zhu, Jian-Ru, Lan, Chun-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559363/
https://www.ncbi.nlm.nih.gov/pubmed/33110448
http://dx.doi.org/10.1177/1756284820937115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559363/
https://www.ncbi.nlm.nih.gov/pubmed/33110448
http://dx.doi.org/10.1177/1756284820937115

Ejemplares similares